The University of Chicago Header Logo


Ezra Cohen to Toll-Like Receptor 7

This is a "connection" page, showing publications Ezra Cohen has written about Toll-Like Receptor 7.
Connection Strength

  1. Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer. JCI Insight. 2017 09 21; 2(18).
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.